Go Pro
→ Gold Explorer Sits Between Barrick’s Nevada Giants (From Wall Street Logic) (Ad)tc pixel Free RPRX Stock Alerts

Royalty Pharma (RPRX) News Today

Royalty Pharma logo
$60.10 -3.87 (-6.04%)
As of 12:27 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Royalty Pharma Latest News

Royalty Pharma (NASDAQ:RPRX) Shares Gap Down - What's Next?
 |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-royalty-pharma-nasdaq-rprx-shares-gap-down-whats-next-2026-09-08/
TD Cowen Issues Positive Forecast for Royalty Pharma (NASDAQ:RPRX) Stock Price
 |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-td-cowen-issues-positive-forecast-for-royalty-pharma-nasdaq-rprx-stock-price-2026-09-08/
Novartis Stock Drops as Trial Failures Ripple Across Biotech Partners
 |  benzinga.comhttps://www.benzinga.com/markets/biotech/26/09/61654807/novartis-stock-drops-as-trial-failures-ripple-across-biotech-partners?utm_source=snapi
Royalty Pharma PLC $RPRX Position Increased by TD Waterhouse Canada Inc.
September 7 at 5:20 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-royalty-pharma-plc-rprx-position-increased-by-td-waterhouse-canada-inc-2026-09-07/
Royalty Pharma announces update on Novartis’ Phase 3 topline results for pelacarsen
September 4, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/royalty-pharma-announces-novartis-phase-230500906.html
Royalty Pharma announces update on Novartis' Phase 3 topline results for pelacarsen
September 4, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/04/3356846/0/en/royalty-pharma-announces-update-on-novartis-phase-3-topline-results-for-pelacarsen.html
Teva posts mid-stage trial win for celiac disease therapy developed with Royalty Pharma
September 2, 2026  |  msn.comhttps://www.msn.com/en-us/news/other/teva-posts-mid-stage-trial-win-for-celiac-disease-therapy-developed-with-royalty-pharma/ar-AA2bpDL8
Public Employees Retirement System of Ohio Makes New $7.84 Million Investment in Royalty Pharma PLC $RPRX
September 2, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-public-employees-retirement-system-of-ohio-makes-new-784-million-investment-in-royalty-pharma-plc-rprx-2026-09-02/
Royalty Pharma (RPRX) Bets $100M On A Blood Disorder Breakthrough
September 1, 2026  |  insidermonkey.comhttps://www.insidermonkey.com/blog/royalty-pharma-rprx-bets-100m-on-a-blood-disorder-breakthrough-1826052/
Royalty Pharma (NASDAQ:RPRX) Sets New 52-Week High - What's Next?
September 1, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-royalty-pharma-nasdaq-rprx-sets-new-52-week-high-whats-next-2026-09-01/
Headlands Technologies LLC Invests $5.09 Million in Royalty Pharma PLC $RPRX
August 31, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-headlands-technologies-llc-invests-509-million-in-royalty-pharma-plc-rprx-2026-08-31/
Royalty Pharma (NASDAQ:RPRX) Downgraded to Buy Rating by Wall Street Zen
August 30, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30991228
Wall Street Zen Downgrades Royalty Pharma (NASDAQ:RPRX) to Buy
August 30, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-wall-street-zen-downgrades-royalty-pharma-nasdaq-rprx-to-buy-2026-08-30/
Royalty Pharma PLC (NASDAQ:RPRX) Given Consensus Recommendation of "Buy" by Brokerages
August 29, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30990271
Royalty Pharma: Strong Execution, Higher Guidance, And Room For A Re-Rating
August 26, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4940417-royalty-pharma-strong-execution-higher-guidance-and-room-for-a-re-rating
Royalty Pharma: The Quiet Compounder The Market Is Still Mispricing
August 26, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4940292-royalty-pharma-the-quiet-compounder-the-market-is-still-mispricing
Odyssean LLC Acquires 21,401 Shares of Royalty Pharma PLC $RPRX
August 26, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-odyssean-llc-acquires-21401-shares-of-royalty-pharma-plc-rprx-2026-08-26/
Royalty Pharma (NASDAQ:RPRX) Hits New 1-Year High - Here's What Happened
August 25, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-royalty-pharma-nasdaq-rprx-hits-new-1-year-high-heres-what-happened-2026-08-25/
Royalty Pharma PLC (NASDAQ:RPRX) Given Consensus Rating of "Buy" by Brokerages
August 24, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/royalty-pharma-plc-nasdaqrprx-given-consensus-rating-of-buy-by-brokerages-2026-08-24/
Wall Street Zen Upgrades Royalty Pharma (NASDAQ:RPRX) to "Strong-Buy"
August 22, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/wall-street-zen-upgrades-royalty-pharma-nasdaqrprx-to-strong-buy-2026-08-22/
Insider Selling: Royalty Pharma (NASDAQ:RPRX) EVP Sells $5,997,000.00 in Stock
August 20, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-rprx-insider-buying-and-selling-2026-08-20/
30,000 Shares in Royalty Pharma PLC $RPRX Purchased by Monetta Financial Services Inc.
August 20, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-30000-shares-in-royalty-pharma-plc-rprx-purchased-by-monetta-financial-services-inc-2026-08-20/
Royalty Pharma (NASDAQ:RPRX) EVP Christopher Hite Sells 100,000 Shares of Stock
August 19, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/royalty-pharma-nasdaqrprx-evp-christopher-hite-sells-100000-shares-of-stock-2026-08-19/
Royalty Pharma (NASDAQ:RPRX) Sets New 1-Year High - Here's What Happened
August 19, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/royalty-pharma-nasdaqrprx-sets-new-1-year-high-heres-what-happened-2026-08-19/
Commerzbank Aktiengesellschaft FI Invests $1.20 Million in Royalty Pharma PLC $RPRX
August 19, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-commerzbank-aktiengesellschaft-fi-invests-120-million-in-royalty-pharma-plc-rprx-2026-08-19/
S&CO Inc. Buys Shares of 358,302 Royalty Pharma PLC $RPRX
August 16, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-sco-inc-buys-shares-of-358302-royalty-pharma-plc-rprx-2026-08-16/
Zealand Pharma enters into a USD 100 million royalty purchase and sale agreement with Royalty Pharma for the economics related to rusfertide
August 12, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/zealand-pharma-enters-into-a-usd-100-million-royalty-purchase-and-sale-agreement-with-royalty-pharma-for-the-economics-related-to-rusfertide-1036449135
Royalty Pharma (RPRX) Q2 2026 Earnings Call Transcript
August 12, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/royalty-pharma-rprx-q2-2026-135928969.html
Royalty Pharma and Zealand Pharma enter into rusfertide funding agreement for $100 million
August 12, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/12/3344086/0/en/royalty-pharma-and-zealand-pharma-enter-into-rusfertide-funding-agreement-for-100-million.html
Royalty Pharma PLC (NASDAQ:RPRX) Plans Quarterly Dividend of $0.23
August 12, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/royalty-pharma-plc-nasdaqrprx-plans-quarterly-dividend-of-023-2026-08-12/
Royalty Pharma PLC $RPRX Shares Sold by Wedge Capital Management L L P NC
August 12, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-royalty-pharma-plc-rprx-shares-sold-by-wedge-capital-management-l-l-p-nc-2026-08-12/
Royalty Pharma PLC $RPRX Stake Boosted by Handelsbanken Fonder AB
August 12, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-royalty-pharma-plc-rprx-stake-boosted-by-handelsbanken-fonder-ab-2026-08-12/
Royal Bank of Canada Purchases 23,479 Shares of Royalty Pharma PLC $RPRX
August 10, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-royal-bank-of-canada-purchases-23479-shares-of-royalty-pharma-plc-rprx-2026-08-10/
Royalty Pharma: Q2 Earnings Snapshot
August 5, 2026  |  chron.comhttps://www.chron.com/business/article/royalty-pharma-q2-earnings-snapshot-22375017.php
Royalty Pharma PLC (RPRX) (Q2 2026) Earnings Call Highlights: Strong Growth and Raised Guidance
August 5, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/royalty-pharma-plc-rprx-q2-190129969.html
Royalty Pharma plc (RPRX) Q2 2026 Earnings Call Transcript
August 5, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4930763-royalty-pharma-plc-rprx-q2-2026-earnings-call-transcript
Royalty Pharma plc 2026 Q2 - Results - Earnings Call Presentation
August 5, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4930752-royalty-pharma-plc-2026-q2-results-earnings-call-presentation
Royalty Pharma reports second quarter 2026 results
August 5, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/05/3339177/0/en/royalty-pharma-reports-second-quarter-2026-results.html
Royalty Pharma: At The Right P/E, I'm In (But Not Here)
August 5, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4930505-royalty-pharma-at-the-right-pe-im-in-but-not-here
Royalty Pharma appoints Greg Raskin as Senior Vice President, Head of Academic Initiatives
August 3, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/03/3337481/0/en/royalty-pharma-appoints-greg-raskin-as-senior-vice-president-head-of-academic-initiatives.html
Royalty Pharma (RPRX) Could Be 40% Undervalued After Its Dividend Decision
July 31, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/royalty-pharma-rprx-could-40-031645447.html
Royalty Pharma acquires royalty interest in AstraZeneca’s cliramitug for up to $425 million from Neurimmune
July 22, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/royalty-pharma-acquires-royalty-interest-in-astrazeneca-s-cliramitug-for-up-to-425-million-from-neurimmune-1036350926
Royalty Pharma acquires royalty interest in AstraZeneca's cliramitug for up to $425 million from Neurimmune
July 22, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/22/3331241/0/en/royalty-pharma-acquires-royalty-interest-in-astrazeneca-s-cliramitug-for-up-to-425-million-from-neurimmune.html
RPRX Stock Price Prediction
July 20, 2026  |  247wallst.comhttps://247wallst.com/companies/rprx/price-prediction
Royalty Pharma declares third quarter 2026 dividend
July 17, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/17/3329283/0/en/royalty-pharma-declares-third-quarter-2026-dividend.html
Royalty Pharma to announce second quarter 2026 financial results on August 5, 2026
July 15, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/15/3328125/0/en/royalty-pharma-to-announce-second-quarter-2026-financial-results-on-august-5-2026.html
Royalty Pharma (NASDAQ:RPRX) EVP Sells 9,099 Shares of Stock
July 3, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-rprx-insider-buying-and-selling-2026-07-03/
Royalty Pharma, plc (RPRX) Rallied on Earnings Beat
June 29, 2026  |  insidermonkey.comhttps://www.insidermonkey.com/blog/royalty-pharma-plc-rprx-rallied-on-earnings-beat-1791459/
Royalty Pharma, plc (RPRX) Rallied on Earnings Beat
June 29, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/royalty-pharma-plc-rprx-rallied-131626725.html
Marshall Urist Sells 9,098 Shares of Royalty Pharma (NASDAQ:RPRX) Stock
June 26, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-rprx-insider-buying-and-selling-2026-06-26/

Royalty Pharma Media Mentions By Week

Royalty Pharma Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

RPRX
News Sentiment
▼
0.56

0.79
▲
Average
Healthcare
News Sentiment

Royalty Pharma News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

RPRX Articles
This Week
▼
10

5
▲
RPRX Articles
Average Week

Royalty Pharma Trends on MarketBeat

This week vs. last week
New Followers
1
Searches
3
Page Views
3,497
+12%
Get Royalty Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for RPRX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools

Related Companies
News and Trends Tools

MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Royalty Pharma dated 9/8/2026.
From Our Partners
Earth's biggest energy source: near Grand Canyon
The largest energy source on Earth contains 50,000 times every oil and gas reserve on the planet combined - an...
Behind the Markets | Sponsoredtc pixel
Why the Treasury still prices gold at 42 dollars an ounce
The U.S. Treasury still values its gold reserves at 42.22 dollars an ounce, a price set in 1973. Gold trades n...
Golden Portfolio | Sponsoredtc pixel
Forget SpaceX, Elon Is Now Powering the Next Hot IPO
Elon Musk is backing a new AI startup that's quietly growing faster than Tesla, SpaceX, and reportedly 23 time...
Brownstone Research | Sponsoredtc pixel
The trade I’ve been waiting for since 2011
Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...
Traders Agency | Sponsoredtc pixel
What Is A Roth Conversion, And How Do I Set One Up?
A Roth conversion moves money from a traditional IRA or employer plan into a Roth IRA, triggering income tax t...
SmartAsset | Sponsoredtc pixel
This looks like plywood. It's not.
AI data centers have a power problem nobody likes to talk about. A single rack of computers can now use more e...
Eagle Publishing | Sponsoredtc pixel
SpaceX pays a 10X launch penalty
SpaceX burns roughly $200,000 in fuel per Falcon 9 launch - about $20 million across 100 missions. One unde...
Freedom Financial | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel